SAGE(Delisted)
Sage TherapeuticsยทNASDAQ
--
--(--)
SAGE fundamentals
Sage Therapeutics (SAGE) released its earnings on Jul 30, 2025: revenue was 31.66M (YoY +266.01%), beat estimates; EPS was -0.79 (YoY +53.53%), beat estimates.
Revenue / YoY
31.66M
+266.01%
EPS / YoY
-0.79
+53.53%
Report date
Jul 30, 2025
EPS
Revenue
Revenue & Expenses
SAGE has released its 2025 Q2 earnings report, with revenue of 31.66M, reflecting a YoY change of 265.84%, and net profit of -49.65M, showing a YoY change of 51.73%. The Sankey diagram below clearly presents SAGE's revenue sources and cost distribution.
Key Indicators
Sage Therapeutics (SAGE) key financial stats and ratios, covering profitability, financial health, and leverage.
Sage Therapeutics (SAGE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Sage Therapeutics (SAGE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Sage Therapeutics (SAGE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Sage Therapeutics (SAGE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Sage Therapeutics (SAGE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
